MRNA spotlight — 2026-11-09
Moderna (MRNA) shares rose 5.27% during Friday's session, closing at $254.19. This move comes amid a period of significant growth; the stock has returned 29.03% over the last month and 325.0% over the last three months.
Key figures
Data as of Nov 9, 2026- MRNA last close
- $254.19
- MRNA change vs prior close
- 5.27%
- MRNA market cap
- $103.93B
Moderna (MRNA) shares rose 5.27%¹ during Friday's session, closing at $254.19². This move comes amid a period of significant growth; the stock has returned 29.03% over the last month³ and 325.0% over the last three months⁴.
With a market cap of $103.93B⁵, MRNA is currently trading at 94.6% of its 52-week range⁶, sitting just below its 52-week high of $267.5⁷ and far above its low of $22.28⁸. This upward momentum is reflected in its distance from long-term averages, as the close is 177.9% above its 200-day average⁹ and 32.5% above its 50-day average¹⁰.
Trading volume on Friday was 16.33 million shares¹¹, which is 0.95x its 20-session average¹². While the stock saw a 14.64% return over the last five sessions¹³, it has closed higher in six of the last ten sessions. The Minervini Trend Template shows a confidence level of 93.1, and none of the six tracked macro regime signals are currently risk-off.
Moderna, Inc. Common Stock (MRNA): price and news
Full chart and figuresEducational tool. Not investment advice. This article was produced with automated assistance. Every figure in it was checked against the underlying data before it was published; the interpretation was not.